SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-05-006306
Filing Date
2005-11-08
Accepted
2005-11-08 16:44:45
Documents
6
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 IDENIX PHARMACEUTICALS, INC. FORM 10-Q b57413ipe10vq.htm 10-Q 405870
2 EX-10.1 AGREEMENT DATED OCTOBER 24, 2005 b57413ipexv10w1.txt EX-10.1 36997
3 EX-31.1 SECTION 302 CERTIFICATION OF CEO b57413ipexv31w1.txt EX-31.1 3846
4 EX-31.2 SECTION 302 CERTIFICATION OF CFO b57413ipexv31w2.txt EX-31.2 3820
5 EX-32.1 SECTION 906 CERTIFICATION OF CEO b57413ipexv32w1.txt EX-32.1 1750
6 EX-32.2 SECTION 906 CERTIFICATION OF CFO b57413ipexv32w2.txt EX-32.2 1752
  Complete submission text file 0000950135-05-006306.txt   455497
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET . CAMBRIDGE MA 02139 (617) 250-3100
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605
Type: 10-Q | Act: 34 | File No.: 000-49839 | Film No.: 051186772
SIC: 2834 Pharmaceutical Preparations